Search research articles
Contact Us
Filters
Showing results (51-60 of 112) with videos related to
Page
of 12
Sort By:
Archives of General Psychiatry
|
August 2, 2000
Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders
G Lambert, M Johansson, H Agren, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 10, 1998
Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour
C Löfberg, H Agren, J Harro, et al.
Psychopharmacology Series
|
January 1, 1989
Neurotransmitter interactions as a target of drug action
W Z Potter, J K Hsiao, H Agren
The Journal of Physical Chemistry. A
|
July 27, 2006
Interplay of one- and two-step channels in electrovibrational two-photon absorption
S Polyutov, I Minkov, F Gel'mukhanov, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1999
Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors
M Landén, E Eriksson, H Agren, et al.
Biological Psychiatry
|
August 25, 1999
The influence of prolactin response to d-fenfluramine on executive functioning in major depression
A Degl'Innocenti, H Agren, O Zachrisson, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1983
Estimation of fetal maturity by amniotic fluid cytology, creatinine, lecithin/sphingomyelin ratio and phosphatidylglycerol
O Tydén, U Eriksson, H Agren, et al.
Journal of Affective Disorders
|
June 7, 2005
Perception of rearing circumstances relates to course of illness in patients with therapy-refractory affective disorders
A Ehnvall, A Palm-Beskow, J Beskow, et al.
Neuroscience Letters
|
December 5, 1994
Increased concentration of calcitonin gene-related peptide in cerebrospinal fluid of depressed patients. A possible trait marker of major depressive disorder
A A Mathé, H Agren, L Lindström, et al.
International Journal of Clinical Practice
|
July 19, 2006
The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression
P Sobocki, M Ekman, H Agren, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 112) with videos related to
Sort By:
Page
of 12
Archives of General Psychiatry
|
August 2, 2000
Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders
G Lambert, M Johansson, H Agren, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 10, 1998
Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour
C Löfberg, H Agren, J Harro, et al.
Psychopharmacology Series
|
January 1, 1989
Neurotransmitter interactions as a target of drug action
W Z Potter, J K Hsiao, H Agren
The Journal of Physical Chemistry. A
|
July 27, 2006
Interplay of one- and two-step channels in electrovibrational two-photon absorption
S Polyutov, I Minkov, F Gel'mukhanov, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1999
Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors
M Landén, E Eriksson, H Agren, et al.
Biological Psychiatry
|
August 25, 1999
The influence of prolactin response to d-fenfluramine on executive functioning in major depression
A Degl'Innocenti, H Agren, O Zachrisson, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1983
Estimation of fetal maturity by amniotic fluid cytology, creatinine, lecithin/sphingomyelin ratio and phosphatidylglycerol
O Tydén, U Eriksson, H Agren, et al.
Journal of Affective Disorders
|
June 7, 2005
Perception of rearing circumstances relates to course of illness in patients with therapy-refractory affective disorders
A Ehnvall, A Palm-Beskow, J Beskow, et al.
Neuroscience Letters
|
December 5, 1994
Increased concentration of calcitonin gene-related peptide in cerebrospinal fluid of depressed patients. A possible trait marker of major depressive disorder
A A Mathé, H Agren, L Lindström, et al.
International Journal of Clinical Practice
|
July 19, 2006
The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression
P Sobocki, M Ekman, H Agren, et al.
Page
of 12